Literature DB >> 8495985

A field study on follow up at 10 years of prevalence of chronic obstructive pulmonary disease & peak expiratory flow rate.

S K Jindal1.   

Abstract

In view of the paucity of follow-up field studies on patients of chronic obstructive pulmonary disease (COPD) with respect to smoking habits and lung function assessment, we undertook re-evaluation of COPD subjects 10 yr later. Of 2825 urban and 1556 rural subjects studied earlier between 1977-80, we re-examined 846 (29.9%) and 629 (40.4%) subjects respectively in 1990. A questionnaire was filled and peak expiratory flow rate (PEFR) was measured in each subject. Symptomatic subjects were grouped into chronic bronchitis, simple (CB, S) and obstructive (CB, AO). The overall prevalence of COPD was 5.0 per cent in male and 2.8 per cent in female subjects. Prevalence of both CB, S and CB, AO were higher in the smokers. In the non-smokers, CB, AO prevalence was similar in the two sexes, but CB, S was commoner in rural than urban women. This simple, hypersecretory disorder was attributed to their exposure to biomass fuel combustion. The fall in PEFR, was significantly higher in smokers than nonsmokers, and more so in the symptomatic subjects with CB, AO. It was concluded that though the overall trend of prevalence of COPD in different groups did not change over the period, those with an initial airways obstruction had deteriorated significantly more than those with normal initial PEFR.

Entities:  

Mesh:

Year:  1993        PMID: 8495985

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  12 in total

Review 1.  Prevalence of COPD in India: a systematic review.

Authors:  Ailsa J McKay; P A Mahesh; Julia Z Fordham; Azeem Majeed
Journal:  Prim Care Respir J       Date:  2012-09

2.  Prevalence and health status of COPD in rural West Bengal.

Authors:  Rupak Kumar Ghosh; Dipanjan Saha; Madan Sarma; Pallav Bhattacharyya; Saibal Majumdar; Abhijit Chowdhury; Parthasarathi Bhattacharyya
Journal:  Lung India       Date:  2022 May-Jun

3.  Validation of a structured questionnaire for COPD and prevalence of COPD in rural area of Mysore: A pilot study.

Authors:  P A Mahesh; B S Jayaraj; S T Prahlad; S K Chaya; A K Prabhakar; A N Agarwal; S K Jindal
Journal:  Lung India       Date:  2009-07

4.  Lung injury after cigarette smoking is particle related.

Authors:  Rahul G Sangani; Andrew J Ghio
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-03-10

5.  Prevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustion.

Authors:  Priscilla Johnson; Kalpana Balakrishnan; Padmavathi Ramaswamy; Santu Ghosh; Muthukumar Sadhasivam; Omprakash Abirami; Bernard W C Sathiasekaran; Kirk R Smith; Vijayalakshmi Thanasekaraan; Arcot S Subhashini
Journal:  Glob Health Action       Date:  2011-11-03       Impact factor: 2.640

6.  A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods.

Authors:  Prabu Rajkumar; Kamaraj Pattabi; Selvaraj Vadivoo; Arvind Bhome; Bill Brashier; Prashanta Bhattacharya; Sanjay M Mehendale
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

7.  Effect of Dietary Supplementation on Body Composition, Pulmonary Function and Health-Related Quality of Life in Patients with Stable COPD.

Authors:  Naushad Ahmad Khan; Naresh Kumar; Mradul K Daga
Journal:  Tanaffos       Date:  2016

8.  Prevalence of respiratory disease and associated factors in an urban area of delhi.

Authors:  Pragti Chhabra; Geetanjali Sharma; Anjur T Kannan
Journal:  Indian J Community Med       Date:  2008-10

9.  Diagnostic Values of Electrocardiogram in Chronic Obstructive Pulmonary Disease (COPD).

Authors:  R L Agarwal; Dinesh Kumar; D K Agarwal; G S Chabra
Journal:  Lung India       Date:  2008-04

Review 10.  Chronic obstructive pulmonary disease.

Authors:  V K Vijayan
Journal:  Indian J Med Res       Date:  2013-02       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.